Fiche personne


Territoire

Lorraine

Statut

Hospitalier

Recherche

Expertises :
- Cancer:Peau
- Clinique:Dermatologie

Publications


The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.

Karine B, Mortier L, Dereure O, Dalac S, Montaudié H, Legoupil D, Dutriaux C, De Quatrebarbes J, Maubec E, Leccia MT, Granel-Brocard F, Brunet-Possenti F, Arnault JP, Gaudy-Marqueste C, Pages C, Saiag P, L'orphelin JM, Zehou O, Lesimple T, Allayous C, Porcher R, Oriano B, Dalle S, Lebbé C

Br J Dermatol. 2024 11 28;:

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.

Macaire C, Lefevre W, Dalac S, Montaudié H, Legoupil D, Dereure O, Dutriaux C, Leccia MT, Aubin F, Grob JJ, Saiag P, De Quatrebarbes J, Maubec E, Lesimple T, Granel-Brocard F, Mortier L, Dalle S, Lebbé C, Prod'homme C

Melanoma Res. 2024 11 11;:

Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment.

Tzoumpa S, Villette B, Granel-Brocard F, Dutriaux C, Memmi A, Jeudy G, Tafani V, Saint-Jean M, Nardin C, Funck-Brentan E, Corre YL, Quereux G, Maubec E

Immunotherapy. 2024 09 13;:1-9

Voir plus